The AAVCOVID vaccine program, a novel gene-based vaccine strategy led by Luk Vandenberghe, PhD, Associate Professor of Ophthalmology at Harvard Medical School and Director of the Grousbeck Gene...

On June 13, Harvard Ophthalmology hosted a successful reimagined Annual and Alumni Virtual Meeting with nearly 300 faculty and alumni attendees. With a central theme of Innovation and Adaptation...

Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types—the most commonly used viral vectors for in...

Luk H. Vandenberghe, PhD, Harvard Medical School Associate Professor of Ophthalmology and Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear, has been named the first incumbent...

In Nature, Luk Vandenberghe, PhD, Harvard Medical School Associate Professor of Ophthalmology and Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear, discusses increasing the...

Luk Vandenberghe, PhD, Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear and Assistant Professor of Ophthalmology at Harvard Medical School, will receive the American Society of...

New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases.

Boston, Mass. — Scientists and advocates today...

Luk H. Vandenberghe, PhD, along with collaborator and lead author Rob Collin, PhD, of Radboud University Medical Center, has been selected to receive the 2017 Ed Gollob Board of Directors’ Award fro...

Improved delivery vector better penetrates the inner ear, also restores balance in a mouse model of Usher syndrome 

Boston, Mass. — In the summer of 2015, a team at Boston Children’s Hospital and...

Boston, Mass. — Luk H. Vandenberghe, PhD, Director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear and an Assistant Professor of Ophthalmology at Harvard Medical School, has been...

• The strategic licensing agreement between Lonza and Massachusetts Eye and Ear® underscores Lonza’s position as a leading AAV manufacturing service provider and offers customers unprecedented...

Faculty Awards

Joseph Arboleda-Velasquez, MD, PhD, and co-PI, Leo Kim, MD, PhD, received a Department of Defense grant in the amount of $1,499,592 over three years, for their project, "Testing...

Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug...

Jason Comander, MD, PhD, received a Foundation Fighting Blindness Enhanced Career Development Award in the amount of $510,000 over three years.

Meredith Gregory-Ksander, PhD, received a grant from ONL...

Claes H. Dohlman, MD, PhD, and Joan W. Miller, MD, were appointed honorary Heed Fellows.

C. Stephen Foster, MD, Massachusetts Eye Research and Surgery Institution, was included in the "America's Best...

Dong Feng Chen, PhD,  received a National Institutes of Health/National Eye Institute R01 grant in the amount of $2,462,500 over five years for her project, "The molecular basis underlying optic...

Boston, MA Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle...